文献速递湿疹皮炎与荨麻疹

成人特应性皮炎的多维负担:一项大型全国性调查的结果

The Multidimensional Burden of Atopic Dermatitis Among Adults: Results From a Large National Survey.
PubMed 文献 · JAMA Dermatol · 2022-01-01

该调查于2019年8月1日至10月11日面向主要为美国成人的特应性皮炎(AD)患者开展,共1065名受访者,使用多变量有序回归评估人口学与临床变量和患者报告总体AD影响评分的关联。结果显示当前AD严重度和管理AD所花时间与总体影响评分关联最强,凸显成人AD的多维负担。

要点

  • 1065名受访者中544人(51%)报告高至显著影响评分(4-5分)。
  • 与轻度相比,中度AD的OR为4.13(95%CI 2.94-5.79),重度AD的OR为13.63(95%CI 8.65-21.50)。
  • 与管理AD少于5小时相比,11-20小时的OR为2.67(95%CI 1.77-4.03),≥21小时的OR为5.34(95%CI 3.22-8.85)。

核心结论

  • 当前AD严重度和管理症状所花时间与疾病负担关联最强。
  • 该分析凸显成人AD的多维负担,并强调需要更有效的治疗策略以减少患者管理AD所花时间。

研究设计与样本

  • 调查性研究,为外部主导的以患者为中心的药物开发会议(与美国食品药品监督管理局就成人AD患者)开展。
  • 调查于2019年8月1日至2019年10月11日进行,数据分析于2021年3月26日至2021年6月29日进行。
  • 共1065名受访者,其中114人(11%)为18至24岁,235人(22%)为25至34岁,242人(23%)为35至50岁,288人(27%)为51至64岁,186人(17%)为65岁及以上;881人(83%)为女性。

主要发现

  • 489名(46%)参与者报告低至中度AD影响评分(2-3分),544名(51%)报告高至显著影响评分(4-5分),32名(3%)报告AD与疾病负担无关(影响评分1分)。
  • 与轻度相比,中度AD的OR为4.13(95%CI 2.94-5.79),重度AD的OR为13.63(95%CI 8.65-21.50)。
  • 与管理AD少于5小时相比,11-20小时的OR为2.67(95%CI 1.77-4.03),≥21小时的OR为5.34(95%CI 3.22-8.85)。

关键数值与推荐

  • 总体AD影响评分采用有序量表,从1分(无影响)到5分(显著影响)。
  • 采用多变量有序回归评估人口学与临床变量和患者报告总体AD影响评分的关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Atopic dermatitis (AD) is long term and burdensome. Studies investigating disease burden in adults are limited in scope with gaps in understanding of the adult patient lived experience. OBJECTIVE: To describe the multidimensional burden of AD among mainly US adults. DESIGN, SETTING, AND PARTICIPANTS: This survey study for an externally led patient-focused drug development meeting with the US Food and Drug Administration on adult patients with AD was conducted between August 1, 2019, and October 11, 2019. Data were analyzed betwean March 26, 2021, and June 29, 2021. MAIN OUTCOMES AND MEASURES: We used multivariable ordinal regression to assess associations between demographic and clinical variables and patient-reported overall AD impact scores (ordinal scale from 1 [no impact] to 5 [significant impact]). RESULTS: Among 1065 survey respondents, 114 (11%) were aged 18 to 24 years, 235 (22%) were 25 to 34 years, 242 (23%) were 35 to 50 years, 288 (27%) were 51 to 64 years, and 186 (17%) were aged 65 years or older; 881 (83%) were women. Four hundred eighty-nine (46%) participants reported low-moderate AD impact scores (2-3), 544 (51%) reported high-significant impact scores (4-5), whereas 32 (3%) reported no association of AD with disease burden (impact score, 1). Variables strongly associated with overall impact scores were current AD severity (moderate: OR, 4.13; 95% CI, 2.94-5.79; severe: OR, 13.63; 95% CI, 8.65-21.50 vs mild), and time spent managing AD (11-20 hours: OR, 2.67; 95% CI, 1.77-4.03, ≥21 hours: OR, 5.34; 95% CI, 3.22-8.85, vs <5 hours). CONCLUSIONS AND RELEVANCE: In this survey study, AD severity and time spent managing symptoms showed the strongest associations with disease burden. This analysis highlights the multidimensional burden of AD in adults and emphasizes the need for more effective treatment strategies that reduce the time patients spend managing their AD.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Elsawi R, Dainty K, Smith Begolka W, et al. The Multidimensional Burden of Atopic Dermatitis Among Adults: Results From a Large National Survey. JAMA Dermatol. 2022. PMID: 35767267. doi:10.1001/jamadermatol.2022.1906

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。